A daptive immunity in jawed vertebrates is underpinned by the use of somatic gene rearrangement to diversify three conserved lineages of lymphocytes: α β T cells, B cells and γ δ T cells 1 . At first impression, the γ δ TCR has high intrinsic diversity, and major expansions of unique γ δ T cell clones have been described, with cytomegalovirus being a candidate driver [2] [3] [4] . Nonetheless, microbe-specific γ δ T cells have proved largely elusive. Instead, human peripheral blood γ δ T cells make generic responses to microbes by recognizing HMBPP (hydroxymethylbut-2-enyl pyrophosphate), an intermediate in sterol metabolism that is more akin to a pathogen-associated molecular pattern. Indeed, HMBPPreactive cells also respond to endogenous sterol intermediates, such as IPP (isopentenyl pyrophosphate), that are upregulated in virusinfected or transformed cells 5 . Likewise, the TCR specificities of rare or unique mouse and human γ δ T cells are seemingly enriched for self-encoded ligands, several of which are closely related to major histocompatibility complex (MHC) proteins [6] [7] [8] [9] [10] [11] . Until the biological importance of such specificities is established, the host benefits of adaptive γ δ TCR diversification will remain unresolved.
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Rather than having clonally restricted reactivity, the V γ 5 V δ 1 TCR of mouse dendritic epidermal T cells (DETCs) is quasi-monoclonal 1, 12, 13 . Likewise, most mouse intestinal IELs express V γ 7 14 . Such extra-lymphoid γ δ T cells exhibit hallmarks of innate immunity in providing rapid, non-clonal responses to local tissue dysregulation [15] [16] [17] [18] . The acquisition of innate-like properties by T cells has been associated with agonist selection during development 19 ; in this context, the development of V γ 5 + DETCs depends on Skint1, a Btnl protein-encoding gene expressed by thymic epithelial cells and suprabasal keratinocytes 20, 21 . Likewise, the development of V γ 7 + IELs depends on Btnl1 expressed by enterocytes 22 . Moreover, consistent with the functioning of Btnl (mouse) or BTNL (human) proteins as heteromers 23 , V γ 7 + IELs respond specifically to cells co-expressing Btnl1 and Btnl6. Indicative of a conserved biology, human colonic γ δ T cells specifically respond to cells co-expressing the enterocyte proteins BTNL3 and BTNL8 22 . Btnl and BTNL proteins are in the B7 superfamily, whose members link innate immunity and adaptive immunity by communicating the prevailing pathophysiological milieu (e.g., the presence of microbes) to lymphocyte co-receptors such as CD28 16 . As an example, Skint1 structurally resembles PD-L1, a B7-related ligand for the inhibitory co-receptor PD-1 24 . Hence, Btnl and BTNL proteins might likewise regulate γ δ T cells via co-receptors. Conversely, the strict association of Btnl and BTNL proteins with γ δ TCR usage might reflect their acting directly via the TCR. Indeed, TCR V γ 9 V δ 2-mediated γ δ T cell responses to HMBPP and to IPP are dependent on butyrophilin 3A1 (BTN3A1) and BTN3A2 23, 25 .
The γδTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness
The possibility that some γ δ TCRs might be specific for monomorphic, self-encoded proteins while others show clonally restricted reactivities has given rise to the view that there are both innate γ δ T cells and adaptive γ δ T cells 26 .
Here we offer a different perspective in showing that signature mouse and human intestinal γ δ TCRs were sufficient to confer responsiveness to discrete Btnl and BTNL proteins. However, the response was in large part mediated by a germline-encoded segment of V γ that neither contributed to nor obviously precluded the binding of antigen to clonally restricted CDRs. Thus, individual γ δ TCRs have an intrinsic ability to combine innate immunity and adaptive immunity, consistent with the multifaceted biology of γ δ T cells.
Results
Mouse TCR V γ 7 mediates responsiveness to Btnl proteins. The signature intestinal γ δ IEL compartment is dominated by V γ 7 + cells, whose development is severely impaired in Btnl1 −/− mice 22 . To assess the diversity of Btnl1-dependent V γ 7 + cells, we expanded a smallscale TCR deep-sequencing analysis 22 , which revealed that the V γ 7 CDR3 (V γ 7
CDR3
) varied in length (from 10 amino acids to 15 amino acids) and varied slightly in sequence composition (Fig. 1a) . Usage of genes encoding the TCRδ chain was diverse, mostly comprising the following four gene segments, particularly when only unique reads were counted so as to correct for clonal expansions: Trdv2-2 (which encodes the V δ 4 chain recognized by monoclonal antibody GL2 27 ), Trdv7, Trdv6D-1 and Trdv6D-2 (Fig. 1b) . In each case, CDR3δ length and composition were highly diverse (Fig. 1c) . Of note, V γ 7 -IELs, which are a minor fraction of gut γ δ T cells and are Btnl1 independent, showed V δ -chain usage largely comparable to that of V γ 7 + IELs, although they showed relative enrichment for use of Trdv1 and Trdv5 ( Supplementary Fig. 1a ). In sum, deep sequencing revealed the sole constant property of Btnl1-dependent IELs to be their usage of the gene segment encoding V γ 7.
In MODE-K mouse intestinal epithelial cells transduced with Btnl1 and Btnl6 (called 'MODE-K.l1l6 cells' here), the gene products showed stoichiometric co-immunoprecipitation ( Supplementary  Fig. 1b ). Primary V γ 7 + IELs downregulate their TCRs specifically when co-cultured with MODE-K.l1l6 cells, but not when co-cultured with MODE-K cells transduced with either Btnl1 or Btnl6 alone or with empty vector (called 'MODE-K.EV cells' here) 22 .
To explore the basis of this, we optimized co-cultures such that ≥ 50% of V γ 7 + IELs upregulated CD25 (the cytokine receptor subunit IL-2Rα ), and of those, most cells downregulated CD122 (the cytokine receptor subunit IL-15Rβ ), downregulated the TCR by ~40% and upregulated CD71 (the transferrin receptor), relative to the expression of those molecules by cells co-cultured with MODE-K.EV cells (Fig. 1d-f ). Such phenotypic changes are typical for T cells experiencing TCR engagement 28 . On the basis of the discrimination between V γ 7 + IELs responsive to Btnl1 plus Btnl6 and those not responsive to Btnl1 plus Btnl6 that was offered by this assay, we performed single-cell flow-cytometry sorting of responsive cells and (informed by the deep-sequencing data) subjected them to gene amplification with primers for genes encoding TCR V γ 7, V δ 7, V δ 2-2 and V δ 6D1/2, followed by sequencing. Consistent with the deep-sequencing data, the 43 TCRγ -TCRδ pairs obtained from two independent sortings of cells from a total of five mice showed V γ 7 CDR3 lengths of 12-15 amino acids paired to unique clones (n) of V δ 7 (n = 25), V δ 2-2 (n = 13) and V δ 6D1/2 (n = 5) with diverse CDR3δ lengths and sequences (Supplementary Table 1 ). V γ 7
+ IEL diversity was evident in the uniqueness of each γ -chain-δ -chain pairing, although some limits were suggested by the observation that ~25% of recovered TCRδ sequences were also identified in the deep-sequencing datasets derived from three independent harvests of IELs (Supplementary Table 1) .
Capturing the TCR diversity noted above, we stably transduced J76 cells (a human TCR-deficient T cell line that can be used to assay TCR bioactivity 29 ) with seven V γ 7-V δ pairs (mo1-mo7) that collectively spanned three different V δ chains, with six being represented in the deep-sequencing datasets (Table 1; cells called  (for example) 'J76-mo1' here). Each pairing was efficiently and comparably expressed on the cell surface, as was moD, a control V γ 5 V δ 1 + DETC TCR (Fig. 2a) . After being incubated with anti-CD3ε , a TCR-cross-linking agent, J76-mo1 cells through J76-mo7 cells showed substantial TCR downregulation relative to that of counterpart transductants cultured with isotype-matched control antibody (Fig. 2b,c) . The expression of CD25 and CD122 by J76 cells was not reliably modulated by anti-CD3ε , which precluded their use as read-outs of TCR responsiveness. However, all transduced cells upregulated the activation marker CD69 in response to anti-CD3ε , albeit variably (Fig. 2b,c) . Of note, TCR downregulation occurs rapidly in response to TCR engagement, whereas CD69 upregulation is a downstream event, which segregated qualitatively but not quantitatively with TCR downregulation (Fig. 2c) .
J76-mo1 cells through J76-mo7 cells were a phenocopy of primary V γ 7
+ IELs in that they also showed TCR downregulation of ~35% to ≥ 50% after co-culture with MODE-K.l1l6 cells but not after co-culture with MODE-K.EV cells (Fig. 2b,c) . In all cases, CD69 was upregulated, correlating qualitatively rather than quantitatively with TCR downregulation (Fig. 2b,c) . Conversely, V γ 5 V δ 1 + J76-moD cells showed neither TCR downregulation nor CD69 upregulation when co-cultured with MODE-K.l1l6 cells (Fig. 2b,c) . However, responsiveness to MODE-K.l1l6 cells was qualitatively restored for J76-mo5.Vδ 1 cells in which the DETC V δ 1 chain of moD was paired with the mo5 V γ 7 chain (the most common V γ 7 sequence in the three deep-sequencing analyses) ( Table 1 and Fig. 2c ). The finding that J76-mo5.V δ 1 cells responded less well than J76-mo5 cells (Fig. 2c ) most probably reflected the fact that the V δ 1 chain (encoded by Trdv4) never ordinarily pairs with V γ 7. Indeed, there was no Trdv4 read in the deep-sequencing data of sorted V γ 7 + cells (Fig. 1b) . From these results, we concluded that different IELderived V γ 7 + TCRs were sufficient to make human J76 cells qualitatively responsive to mouse Btnl1 and Btnl6, largely irrespective of V δ usage and CDR3γ and CDR3δ composition. Nonetheless, different, comparably expressed V γ 7 + TCRs showed quantitative variation in responsiveness both to Btnl1 plus Btnl6 and to anti-CD3ε (Fig. 2c) .
The comparable kinetics of CD69 upregulation by J76-mo5 cells stimulated with either MODE-K.l1l6 cells or anti-CD3ε ( Supplementary Fig. 2a ) further suggested that the V γ 7-dependent responses reflected TCR engagement. Likewise, the transcription factor Nur77, encoded by the TCR-responsive gene NR4A1 30 , was substantially and significantly upregulated by J76-mo5 cells exposed to anti-CD3ε or MODE-K.l1l6 cells but not those exposed to MODE-K.EV cells (Fig. 2d) , a phenocopy of the response of primary IELs from Nur77.eGFP transgenic mice 22 .
To preclude the possibility that responsiveness to MODE-K. l1l6 cells reflected some unexplained facet of TCR-transduced J76 cells, we transduced mo1 and mo5 TCRs (Table 1) into JRT3 cells (a TCR-deficient Jurkat human T lymphocyte cell line) stably transfected with a luciferase gene reporter under the control of a transcription factor NFAT-dependent promoter 31 , thereby generating 'JRT3-mo1' and 'JRT3-mo5' cells. After co-culture with MODE-K.l1l6 cells, but not after co-culture with MODE-K.EV cells, JRT3-mo1 and JRT3-mo5 cells showed TCR downregulation, CD69 upregulation and induced luciferase activity, while no such responses were shown by V γ 5 V δ 1 + JRT3-moD cells ( Supplementary  Fig. 2b ). Similarly, exposure to anti-CD3ε or to MODE-K.l1l6 cells elicited IL-2 secretion as well as moderate TCR downregulation and CD69 upregulation by the Jurkat subclone E6.1 transduced with mo5 ( Supplementary Fig. 2c ). In sum, the ability of the mouse V γ 7 + mo5 TCR to confer responsiveness to Btnl1 plus Btnl6 onto several human T cell lines strongly suggested that reactivity was mediated by the TCR itself. Moreover, J76-mo5 cells, J76-mo1 cells and primary V γ 7 + IELs responded qualitatively to Btnl1 plus Btnl6 expressed by live or fixed cells and by cells of different originshuman kidney (293T cells), hamster ovary (CHO cells), and mouse gut (MODE-K cells) or skin (PAM2.12 cells) ( Supplementary  Fig. 2d-g ) -which made it unlikely that the V γ 7 + TCR response was to an undefined molecule (or molecules) co-expressed with Btnl1 plus Btnl6. Thus, the Btnl-dependent selection of the signature mouse intestinal γ δ IEL compartment most probably reflected direct interactions of V γ 7 + TCRs with Btnl1 plus Btnl6.
TCR-mediated responsiveness to BTNL proteins is conserved.
Like their V γ 7 + mouse counterparts, human colonic γ δ T cells localized mainly to the IEL compartment (Fig. 3a) . Such cells have been reported to respond ex vivo specifically to cells co-transduced with human BTNL3 and BTNL8, which are expressed mainly by gut epithelial cells 22 . To investigate the basis of this responsiveness, we optimized the co-culture of primary colonic T cells with 293T cells expressing BTNL3 plus BTNL8 (called '293T.L3L8 cells' here). Across several healthy donors, the predominant gut γ δ T cell population, reactive to an antibody specific for V γ 2, V γ 3 and V γ 4 chains 32 (called 'V γ 2/3/4 + cells' here) ( Supplementary Fig. 3a ), showed consistent TCR downregulation of ~45% and variable CD25 upregulation, relative to the expression of those molecules by cells incubated with 293T.EV cells (Fig. 3b and Supplementary Fig. 3b ). These responses were not observed in colonic γ δ T cells expressing none of the V γ 2, V γ 3 or V γ 4 chains (called 'V γ 2/3/4 -cells' here), V δ 2 + T cells (typical of blood γ δ T cells) or α β T cells ( Fig. 3b and Supplementary Fig. 3b ).
The optimized assay described above permitted γ δ T cells responsive to BTNL3 plus BTNL8 to be sorted as single cells on the basis of TCR downregulation (donor 1) or TCR downregulation and CD25 upregulation (donors 2 and 3) (Fig. 3c) . The 19 γ δ TCR pairs (hu1-hu19) recovered from the cells responsive to BTNL3 plus BTNL8 were dominated by V γ 4 chains (17 of 19) with variable CDR3 composition and length (9-14 amino acids) paired to either V δ 1 chains (12 of 19) or V δ 3 chains (7 of 19) displaying highly diverse CDR3 regions ( Table 2) . Although all 19 sequences recovered were unique, ~50% were identified in the deep-sequencing datasets, albeit at different frequencies (Table 2) . Three V γ 4 V δ 1 + TCR pairs (hu7, hu12 and hu17) displaying diverse CDR3γ and CDR3δ sequences and ranging from high representation to very low representation (rare) in the deep-sequencing reads (Table 2) were cloned and used to transduce J76 cells (called 'J76-hu7' , 'J76-hu12' and 'J76-hu17' , respectively, here), while a peripheral blood-derived V γ 9 V δ 2 TCR was used to generate the control cell line J76-huPB. J76-hu7, J76-hu12 and J76-hu17 cells displayed reasonably comparable surface expression of the TCR ( Supplementary Fig. 3c ), which was substantially downregulated in response to anti-CD3ε or to co-culture with 293T.L3L8 cells, but not in response to co-culture with 293T.EV cells (Fig. 3d,e) . CD69 was likewise upregulated in response to 293T.L3L8 cells or to anti-CD3ε , although the magnitude of this varied across the three transduced cell lines (Fig. 3d,e) . Conversely, J76-huPB cells showed neither TCR downregulation nor CD69 upregulation in response to 293T. L3L8 cells but did show responsiveness to anti-CD3ε (Fig. 3e) . Of note, TCR downregulation by J76-hu-transduced cells responding to 293T.L3L8 cells (Fig. 3e ) was usually greater than that shown by J76-mo-transduced cells responding to MODE-K.l1l6 cells (Fig. 2c ), possibly reflective of the different signaling modalities of human γ δ TCRs and mouse γ δ TCRs 33 . J76-hu12 cells responded to BTNL3 plus BTNL8 expressed by different cell types, including human J76 T cells and mouse MODE-K cells ( Supplementary Fig. 3d ). Likewise, JRT3 cells transduced with hu12 showed NFAT activation-dependent luciferase activity following exposure to either 293T.L3L8 cells or the phorbol ester PMA plus ionomycin, whereas control V γ 9 V δ 2 + JRT3. huPB cells responded only to PMA plus ionomycin ( Supplementary  Fig. 3e ). These data indicated that the constant feature of cells responsive to BTNL3 plus BTNL8 was V γ 4.
BTNL-responsiveness requires TCR HV4. 2 of the 19 γ δ TCR pairs recovered from the single-cell-sorted, BTNL-responsive human colonic γ δ T cells expressed V γ 2, which differs from V γ 4 by only nine amino acids (Fig. 4a) . We thus investigated whether V γ 2 could also confer responsiveness to BTNL3 plus BTNL8 or whether the recovery of V γ 2 + TCRs was from cells with stochastically low TCR expression during the cell sorting. To this end, we transduced J76 cells with a modified version of hu17 (hu17.V γ 2) in which the V γ 4 segment was replaced by the V γ 2 chain, while CDR3γ and the same V δ 1 chain were preserved ( Supplementary Fig. 4a ). The resultant transductants showed neither TCR downregulation nor CD69 upregulation in response to co-culture with 293T.L3L8 cells ( Fig. 4b and Supplementary Fig. 4b) .
Three of the amino-acid differences between V γ 2 and V γ 4 map to CDR1 and CDR2 (Fig. 4a) . Therefore, J76 cells were transduced with modified versions of hu17 in which V γ 4 CDR1 and/or CDR2 were replaced by the corresponding V γ 2 sequences (hu17. V γ 2 CDR1 , hu17.V γ 2 CDR2 and hu17.V γ 2 CDR1+2 (where 'CDR1+ 2' indicates 'CDR1 plus CDR2')) ( Supplementary Fig. 4a ). After being cocultured with 293T.L3L8 cells, the resultant transductants showed TCR downregulation and CD69 upregulation comparable to that of J76-hu17 cells ( Fig. 4b and Supplementary Fig. 4b ), which indicated that the failure of V γ 2 to respond to BTNL3 plus BTNL8 did not map to the CDRs.
V γ 2 also differs from V γ 4 by four amino acids in a sub-region of framework region 3 (FR3) known as 'hypervariable region 4' (HV4) because of its variability among different antigen receptors ( Of the four amino acids that distinguish V γ 4 HV4 from V γ 2
HV4
(DGKM versus YANL), exchange of only the two most amino-terminal residues (hu17 DG>YA ) was sufficient to abolish responsiveness to BTNL3 plus BTNL8, whereas exchange of the remaining two residues (hu17 KM>NL ) ( Supplementary Fig. 4a ) was well tolerated ( Fig. 4c and Supplementary Fig. 4c ). Reciprocally, insertion of DG from Supplementary  Fig. 4a ) was sufficient to confer onto J76-hu17.V γ 2 YA>DG cells strong responsiveness to BTNL3 plus BTNL8 ( Fig. 4d and Supplementary  Fig. 4d ). The V γ 3 segment is further diverged from V γ 4 than is V γ 2 ( Fig. 4a) . Thus, J76-hu17.V γ 3 cells transduced with a variant of hu17 in which V γ 3 was substituted for V γ 4 predictably failed to show TCR downregulation or CD69 upregulation when co-cultured with 293T.L3L8 cells ( Fig. 4d and Supplementary Fig. 4a,d ). However, J76-hu17.V γ 3-V γ 4 HV4 cells, in which V γ 3 HV4 was replaced by V γ 4 HV4 , partially recovered responsiveness ( Fig. 4d and Supplementary  Fig. 4a,d ). Completely consistent results were obtained when NFATdependent luciferase activity was measured in JRT3 cells transduced with hu17, hu17
HV4 ( Supplementary Fig. 4e ). Collectively, these results showed that the amino-terminal portion of V γ 4 HV4 was necessary and sufficient for transduced T cells to respond to 293T.L3L8 cells, although its potency was evidently modified by other sequences within the V γ segment.
The role of HV4 is evolutionarily conserved. Next we investigated the basis of the responsiveness of mouse V γ 7 TCRs to Btnl1 plus Btnl6. Although mouse V γ regions differ greatly from each other, V γ 6 shares some similarities with V γ 7, in particular the properties of the amino acids surrounding the CDRs and the length of the serine-rich CDR2 (Fig. 5a ). Therefore, J76 cells were transduced with mo5.V γ 6, in which V γ 7 was replaced by V γ 6 while the V γ 7 CDR3 was preserved ( Fig. 5a ). These J76-mo5.V γ 6 cells expressed the V γ 6 V δ 2-2 + cells. Data are pooled from three experiments (mean ± s.d.). *P < 0.05, **P < 0.01 and ***P < 0.001 (paired two-tailed Student's t-test).
TCR at the cell surface, albeit at a slightly lower level than that of J76-mo5 cells ( Supplementary Fig. 5a,b ), but they neither downregulated the TCR nor upregulated CD69 in response to MODE-K.l1l6 cells (Fig. 5b and Supplementary Fig. 5b ). In contrast, cells transduced with mo5.V γ 6
CDR1
, in which V γ 7 CDR1 (RTGTY) was replaced by V γ 6 CDR1 (TSVQKPDAY) (Fig. 5a ), showed only partially reduced responsiveness to Btnl1 plus Btnl6 relative to that of J76-mo5 cells ( Fig. 5b and Supplementary Fig. 5a 9.3% 1 4.2% 9.3% 20.2% Table 2 ) and co-cultured for 5 h with 293T.L3L8 cells or anti-CD3ε (OKT3) (key); results were normalized to those obtained by co-culture with 293T.EV cells or IgG, respectively. Each symbol represents an individual co-culture. Data are representative of three independent experiments (mean ± s.d. of n = 3 co-cultures).
when both CDR1 and CDR2 of V γ 7 were replaced by the equivalent regions from V γ 6 (mo5.V γ 6 CDR1+2 ) (Fig. 5a,b and Supplementary  Fig. 5a, b) . In sum, CDR1 and CDR2 residues were not essential for V γ 7-mediated responsiveness to Btnl1 plus Btnl6, although the composition of CDR2 in particular did influence the potency of the response.
Because mouse V γ 7 is more closely related to human V γ 4 and V γ 2 than to any other mouse V γ region, sequence alignment allowed us to identify four residues, (H, E, K and F) in mouse V γ 7 HV4 (KYHVYEGPDKRYKFVL) that corresponded to the four residues (D, G, K and M) at which human V γ 4 HV4 differed from V γ 2 HV4 ( Supplementary Fig. 5c ), two of which (D and G) were shown to be essential for the responsiveness to BTNL3 plus BTNL8 (Fig. 4c) . On the basis of that, we transduced J76 cells with a construct (mo5 HEF>DGM ) in which the mouse V γ 7 residues (HEKF) were replaced by their human V γ 4 counterparts (DGKM) (Supplementary Fig. 5c ). When co-cultured with MODE-K.l1l6 cells, these J76-mo5
HEF>DGM cells showed neither TCR downregulation nor CD69 upregulation ( Fig. 5c and Supplementary Fig. 5d ). Likewise, mo5 constructs carrying exchanges of single amino acids between mouse V γ 7 HV4 and human V γ 4 HV4 (mo5 H>D and mo5 E>G ) ( Supplementary Fig. 5c ) identified two residues (H and E) in the amino-terminal portion of V γ 7 HV4 that were essential for responding to Btnl1 plus Btnl6 (Fig. 5c and Supplementary Fig. 5d ) and that occupied positions equivalent to those of the two residues (D and G) that determined the responsiveness of human V γ 4 to BTNL3 plus BTNL8. Indeed, whereas replacement of mouse V γ 7 HV4 in mo5 with human V γ 4 HV4 (mo5-huV γ 4 HV4 ) ( Supplementary Fig. 5c ) abolished responsiveness to Btnl1 plus Btnl6, there was a compensatory gain of responsiveness (TCR downregulation and CD69 upregulation) to cells expressing human BTNL3 plus BTNL8 (Fig. 5d) . Thus, responsiveness to Btnl and BTNL proteins is determined by HV4 motifs whose positioning is evolutionarily conserved and that are functionally interchangeable.
BTNL3 and Btnl6 CFG faces interact with HV4. The molecular structure of a human V γ 4 V δ 1 TCR (PDB accession code 4MNG) 7 revealed that HV4 formed a solvent-exposed loop ( Supplementary  Fig. 6a ). Because we occasionally observed TCR downregulation and CD69 upregulation in V γ 4 V δ 1-transduced cells co-cultured with 293T.L3 cells but not those co-cultered with 293T.L8 cells (Fig. 6a) , we investigated whether the V γ 4 HV4 loop might mediate responses to solvent-exposed residues of BTNL3 versus BTNL8. To this end, we derived a model for the BTNL3-BTNL8 dimer from the X-ray structure of a BTN3A1 homodimer (PDB accession code 4F80) 34 using the in-house homology program 3D-JIGSAW 35 ( Supplementary Fig. 6b ). Second, for each modeled chain, sequence alignment allowed beta-strand demarcation (A, B, C, C' , C", D, E and F) according to the convention for members of the immunoglobulin superfamily ( Supplementary Fig. 6c,d ). Third, candidate solvent-exposed motifs that differed in the amino-terminal immunoglobulin V (IgV) domains of BTNL3 versus those of BTNL8 were identified as NQFHA versus GQFSS in the C strand; EDWESK versus KDQPFM in the C" strand; WF versus RI in the F strand; and Amino acid sequences (bold underlining as in Table 1 ) of CDR3γ and CDR3δ sequenced from colonic IELs responding to BTNL3 plus BTNL8 (donors 1-3; hu1-hu19; Fig. 3 ), with corresponding frequencies and ranks in the corresponding deep-sequencing data; from colonic IELs stained with CD1c-PC dextramers (donor 4; hu20; Fig. 7) ; from peripheral blood γ δ lymphocytes (donor 5; huPB), and from skinderived IELs (donor 6; sk1 and sk2; Supplementary Fig. 7c ). Lymphocytes isolated from donors 4-6 were not subjected to deep sequencing. Bold rows (hu7, hu12, hu17, hu20, huPB, sk1 and sk2) indicate V γ -V δ TCR pairs used to transduce J76 cells. NA, not applicable.
DEEAT versus YQKAI in the G strand ( Fig. 6b and Supplementary  Fig. 6c ). Fourth, unrestricted docking simulations between V γ 4 and the BTNL3 IgV domain using the in-house, publicly available docking server SwarmDock 36 produced solutions that converged on an interaction of V γ 4 HV4 with the CFG face of BTNL3 ( Supplementary  Fig. 6e ) that harbors three of the sets of residues that distinguish BTNL3 from BTNL8. Of note, immunoglobulin-fold CFG faces are established mediators of protein-protein interactions 37 . On the basis of those findings, we co-expressed hemagglutinin (HA)-tagged BTNL8 in 293T cells with either FLAG-tagged BTNL3 or with each of four FLAG-tagged BTNL3 constructs in which the candidate C, C", F and G motifs were replaced by their counterpart BTNL8 sequences (L3   GQFSS   , L3   KDQPFM   , L3 RI and L3 YQKAI ) (Fig. 6c) . Although each was comparably expressed (Supplementary Fig. 6f ), only 293T.L3L8 cells and 293T.L3 KDQPFM L8 cells induced TCR downregulation and CD69 upregulation in co-cultured J76-hu17 cells (Fig. 6c) . These results, together with the solutions offered by SwarmDock (above), permitted us to propose a refined docked complex in which unique residues in the CFG face of BTNL3 mediate functional interactions with V γ 4 HV4 (Fig. 6d) . Recombinant, monomeric, human V γ 4 V δ 2 + or V γ 4 V δ 1 + soluble TCRs, but not V γ 2 V δ 1 + or V γ 8 V δ 1 + soluble TCRs, showed dosedependent staining of 293T.L3L8 cells but not of 293T.EV cells (Fig. 6e,f) , which indicated that TCR V γ 4 most probably interacted specifically and directly with BTNL3-BTNL8. Consistent with that, the V γ 4 V δ 2 + and V γ 4 V δ 1 + soluble TCRs specifically stained mouse MODE-K.L3L8 cells (Supplementary Fig. 6g ). Of note, the lower mean fluorescence intensity of the staining of MODE-K.L3L8 cells relative to that of 293T.L3L8 cells correlated with the relative expression of BTNL3 plus BTNL8 on the two cell types (Supplementary Fig. 6h ).
Next we identified motifs on the CFG faces of mouse Btnl1 and Btnl6 that correspond to the BTNL3 residues proposed to interact with V γ 4 HV4 ( Supplementary Fig. 6i,j) . Thus, we generated 293T cells that co-expressed Btnl1 with either wild-type Btnl6 or each of three mutants in which the Btnl6 C-, F-or G-strand residues were replaced by their Btnl1 counterparts (l6 AQPTP , l6 Q or l6 SQEVS ) (Fig. 6g) . Likewise, we generated 293T cells co-expressing Btnl6 with either wild-type Btnl1 or mutants in which the Btnl1 C-, F-, G-strand residues were replaced by their Btnl6 counterparts (l1 SRFSA , l1 H or l1 YEEAI ) (Fig. 6g) . Only 293T cells expressing wild-type Btnl6 elicited TCR downregulation and CD69 upregulation in co-cultured J76-mo5 cells; 293T cells expressing mutant forms of Btnl6 did not ( Fig. 6g and Supplementary Fig. 6k ). In sum, these results revealed that functional responsiveness to mouse TCR V γ 7 HV4 and human TCR V γ 4 HV4 was mediated by amino-acid motifs in evolutionarily conserved positions on the CFG faces of Btnl6 and BTNL3, respectively. In both cases, the critical motifs mapped to only one of the two Btnl or BTNL chains required for activity.
Human and mouse γδTCRs show dual reactivity. The human V γ 4 V δ 1 + TCR structure used for modeling was previously shown to react to a complex of the antigen-presenting molecule CD1d and sulfatide (CD1d-sulfatide), largely via V δ 1 CDR1-CDR3 (V δ 1 ). According to our refined docked complex model (Fig. 6d) , the V γ 4 V δ 1 + TCR might simultaneously engage CD1d-sulfatide and BTNL3-BTNL8 expressed by the same cell (Fig. 7a) . To further investigate the possibility of dual TCR reactivity, we used a V γ 4 V δ 5 + TCR derived from the LES human γ δ T cell clone that responds to cytomegalovirus-infected cells and to a spectrum of human carcinomas, including gut-derived HT29 cells 8 . These TCR-dependent responses are attributable to a unique specificity for the CD1-related protein EPCR (endothelial protein C receptor), mediated largely by the V γ 4 CDR3. We found that JRT3 cells transduced with the LES TCR (JRT3-LES cells) showed significant, albeit low, levels of TCR downregulation and substantial upregulation of CD69 when co-cultured with either HT29 cells or 293T cells overexpressing EPCR (293T.EPCR cells) (Fig. 7b) . Furthermore, CD69 upregulation was completely or partially inhibited when the co-cultures were supplemented with antibody to EPCR (Supplementary Fig. 7a ). By contrast, JRT3-hu12 cells did not show these responses (Fig 7b) . However, JRT3-LES cells and JRT3-hu12 cells both showed TCR downregulation and CD69 upregulation when co-cultured with 293T.L3L8 cells or 293T.EPCR+ L3L8 cells, which overexpress BTNL3 and BTNL8 (Fig 7b) . Moreover, this response was unaffected by EPCR-reactive antibodies (Supplementary Fig. 7a ). Thus, JRT3-LES cells displayed a clonally restricted TCR reactivity toward EPCR and a non-clonal TCR reactivity toward BTNL3 plus BTNL8.
Within 5 min of being mixed together, co-cultures of JRT3-LES cells with 293T.EPCR, 293T.L3L8 or 293T.EPCR+ L3L8 cells displayed increased levels of phosphorylation of the signaling protein PLC-γ and of the adaptor LAT, relative to that of co-cultures of JRT3-LES cells with 293T.EV cells, as judged by immunoblot analysis ( Supplementary Fig. 7b ). This result indicated that activation via either of the LES TCR specificities (EPCR or BTNL3 plus BTNL8) could converge on equivalent downstream signaling pathways. Because the V γ 4 V δ 5 + LES TCR is blood derived, the results also indicated that reactivity to BTNL3 plus BTNL8 extended beyond gut-derived V γ 4 + TCRs. Indeed, J76 cells transduced with either of two human skin-derived V γ 4 V δ 1 + TCRs (sk1 or sk2) also showed TCR downregulation and CD69 upregulation when co-cultured with 293T.L3L8 cells (Supplementary Fig. 7c ). Thus, seemingly irrespective of their tissue of origin, TCR V γ 4 chains drove non-clonal responses to BTNL3 plus BTNL8.
To determine if dual reactivity could be observed in primary intestinal γ δ T cells from a healthy donor, we sorted colonic V δ 1 Fig. 4a ) and of mo5 variants (bottom; red font indicates difference from wild-type V γ 7 sequence); shading indicates CDR1 (green), CDR2 (yellow) and CDR3 (cyan); the sequence of the most carboxy-terminal region (YYCASWA; identical in all constructs) is omitted here due to space constraints. b,c, Flow-cytometry analysis of TCR downregulation and CD69 upregulation (plotted as in Fig. 4b-d ) by J76 cells transduced with mo5 or its variants ( Supplementary Fig. 5a,b,c,d Fig. 6c,d) . c, Flow-cytometry analysis of TCR downregulation (top) and CD69 upregulation (bottom) by J76-hu17 cells co-cultured for 5 h with 293T cells transfected to express BTNL8 together with either BTNL3 (L3L8) or BTNL3 constructs in which various motifs were replaced with their BTNL8 counterparts (key); results were normalized to those of cells co-cultured with 293T cells transfected with empty vector. Each symbol represents an individual co-culture. Data are representative of three independent experiments (mean ± s.d. of n = 3 co-cultures). IELs on the basis of their binding to dextrameric multimers of CD1c in complex with phosphatidylcholine (CD1c-PC) ( Supplementary  Fig. 7d ). Of 24 V δ 1 + cells sorted and subjected to TCR sequencing, 21 were V γ 5 V δ 1 + and 2 were V γ 8 V δ 1 + , but 1 was V γ 4 V δ 1 + , from which the TCR (hu20) was used to transduce J76 cells (Table 2) . J76-hu20 cells were stained specifically by CD1c-PC, whereas J76-hu17 cells were not (Fig. 7c) . However, both cell lines showed strong responsiveness to 293T.L3L8 cells (Fig. 7d) . Thus, J76-hu20 cells showed clonally restricted TCR binding of CD1c-PC and non-clonal responsiveness to BTNL3 plus BTNL8. + TCR (key) and cocultured for 5 h with various MODE-K or 293T cell lines (horizontal axis); results are normalized to those of cells co-cultured with MODE-K.EV or 293T. EV cells, respectively. Each symbol represents an individual co-culture. Data are representative of five independent experiments (mean ± s.d. of n = 3 cocultures). *P < 0.05, **P < 0.01 and ***P < 0.001 (paired two-tailed Student's t-test).
Finally, we investigated whether dual reactivity also extended to primary mouse intestinal γ δ IELs, ~0.5% of which reportedly bind to the very closely related MHC class I-like molecules T10 and T22 via a specific CDR3δ motif 6 . The same CDR3δ motif was found in the V γ 7 V δ 7 + TCR of mo8 (clone 24, Supplementary Table 1) , and J76-mo8 cells showed TCR downregulation and CD69 upregulation in response to cells overexpressing T22 (MODE-K.T22 or 293T.T22 cells), as well as to cells overexpressing Btnl1 plus Btnl6 (MODE-K. l1l6, 293T.l1l6, MODE-K.T22+ l1l6 or 293T.T22+ l1l6 cells) (Fig. 7e and Supplementary Fig. 7e) . Moreover, immunoblot analysis showed increased phosphorylation of PLC-γ and LAT in J76-mo8 cells co-cultured with MODE-K.l1l6, MODE-K.T22 or MODE-K. T22+ l1l6 cells, relative to that of co-cultures with MODE-K.EV cells (Supplementary Fig. 7f) . Conversely, J76-mo5 cells responded only to cells expressing Btnl1 plus Btnl6 (Fig. 7e) . Thus, J76-mo8 cells showed clonally restricted responsiveness to T22 and nonclonal TCR responsiveness to Btnl1 plus Btnl6. Furthermore, recognition of 293T.T22 cells by J76-mo8 cells (Fig. 7f) showed that the clonally restricted response did not depend on the non-clonal response, since Btnl1 and Btnl6 were not expressed by 293T cells. In sum, mouse V γ 7 + TCRs and human V γ 4 + TCRs share an intrinsic ability to mediate responses to two qualitatively distinct types of stimulus: antigen, and Btnl-or BTNL-encoded agonists.
Discussion
Here we have identified an evolutionarily conserved mechanism by which the γ δ TCR mediates the regulation of mouse and human intestinal γ δ IELs by epithelial Btnl and BTNL proteins. Mouse V γ 7 + TCRs and human V γ 4 + TCRs were sufficient to confer qualitative responsiveness to Btnl1 plus Btnl6 and to BTNL3 plus BTNL8, respectively, whereas TCRs expressing different V γ segments were not. Complementary loss-of-function and gain-of-function experiments mapped most of the responsiveness to Btnl proteins and BTNL proteins to equivalent positions in the germline-encoded HV4 regions of mouse V γ 7 and human V γ 4, respectively. Thus, specific TCR V γ regions can use germline-encoded motifs to mediate responses to endogenous agonists, suggestive of an innate interaction germane to the heritability of genes encoding TCR V γ regions.
Molecular modeling identified a means by which human V γ 4 HV4 might interact directly with the CFG face of the amino-terminal IgV domain of BTNL3. In support of that model were mutagenesis studies that likewise linked the CFG face of the Btnl6 IgV domain to engagement of mouse V γ 7
HV4
. Of note, CFG faces mediate heterotypic interactions of numerous proteins of the immunoglobulin superfamily, including CD2, CD4, VCAM and MADCAM [38] [39] [40] [41] . These results suggest a conserved mechanism whereby the regulation of γ δ IELs by Btnl or BTNL proteins is mediated by an 'interacting chain' (Btnl6 or BTNL3) coupled to a 'supporting chain' (Btnl1 or BTNL8) that jointly determine biological activity. Moreover, this conservation might extend to the collaborative regulation, by BTN3A1 and BTN3A2, of human peripheral blood γ δ T cell responses to HMBPP 23 . Beyond the requirement for mouse V γ 7 or human V γ 4, respectively, Btnl-or BTNL-responsive γ δ IELs are diverse, expressing various TCRδ chains with diverse CDR3 regions. Although our data have shown that the potency of the interactions of mouse V γ 7 and human V γ 4 with Btnl6 and BTNL3, respectively, can be affected by V-region residues outside of HV4, particularly CDR2γ , the structural modeling suggests that clone-specific CDR3 regions could remain available to engage clonally restricted antigens, irrespective of the engagement of Btnl or BTNL proteins. Consistent with that, we demonstrated dual specificities for two human BTNL-responsive V γ 4 + TCRs and for a mouse Btnl-responsive V γ 7 + TCR, with different sub-regions of the CDRs associated with ligand binding 6, 8 . Such spatially discrete dual specificities, involving HV4 and CDR1-CDR3, respectively, are distinct from commonly described cross-reactivities of CDR1-CDR3 regions in other types of antigen receptors. Instead, the γ δ TCR has an intrinsic ability to use a discrete germline-encoded region to mediate innate, non-clonal responses to an endogenous agonist and to use recombinase-dependent regions to mediate adaptive, clone-specific responses to diverse ligands. Although it is not necessarily the case that selecting agonists and clonally restricted ligands would be co-expressed, γ δ T cells might use their TCRs to simultaneously engage agonists and clonally restricted ligands displayed on different cells. These findings offer a framework for reconciling the innate-like biologies of γ δ T cells with their adaptive, highly individual clonal dominance patterns [2] [3] [4] . RNAs encoding Btnl and BTNL proteins seem to be expressed by differentiated enterocytes. Thus, following γ δ IEL selection, Btnl and BTNL proteins might sustain steady-state interactions with neighboring IELs, akin to the tonic signaling that is proposed to sustain the survival and/or competence of peripheral α β T cells 42 . Indeed, steady-state engagement of ligand by HV4 might induce in primary IELs signaling events different from those induced by the binding of ligand to CDR1-CDR3. In this context, there is no evidence that Btnl (or BTNL) interactions determine peripheral clonal dominance; thus, fairly comparable responses to 293T. L3L8 cells were mediated by TCRs that were either highly abundant (e.g., hu12) or rare (e.g., hu7) in the deep-sequencing dataset. Conceivably, tonic signaling of α β T cells might also be a 'neutral event' that does not influence clonal dominance.
Each of the clonally restricted TCR antigens considered in this study is an MHC-related molecule. Although neither MHC molecules nor CD1 molecules are required for development of the γ δ T cell repertoire, their potential to function as clone-specific ligands is well established 18, 43 . Several such ligands have been considered 'stress antigens' , promoting γ δ T cell responses to dysregulated tissues, including cancer cells. Thus, the γ δ TCR might use HV4 to sense 'normal self ' and use CDR1-CDR3 to sense 'stressed self ' , in which context it is intriguing that Btnl and BTNL proteins are related to B7 proteins that communicate pathophysiological contexts to regulate the responses of adaptive lymphocytes. In this context, the quasi-monomorphic DETC receptor might have a Btnl-like ligand (such as a Skint1 complex) at steady state and a qualitatively distinct ligand (or ligands) on dysregulated cells 44 . The apparently generalizable ability of HV4 to form a solventexposed loop in γ δ TCRs raises the question of whether it is broadly deployed to engage self agonists. There is evidence for agonist selection of several γ δ T cell subsets 45, 46 , and HV4-mediated agonist selection might in particular underpin the development of several tissue-associated γ δ T cell compartments that display restricted V γ -chain usage and that effect different pre-programmed functions in response to myriad innate stimuli 18 . Moreover, in cases in which TCR signaling promoted death in developing γ δ T cells 47 , it might be appropriate to evaluate whether this is also true for HV4-dependent signals.
Likewise, our findings might have implications for α β TCR + natural killer T cells and mucosa-associated T cells, which are partly defined by highly restricted TCR V α -chain usage and undergo self-agonist selection before making rapid, polyclonal responses to innate stimuli, such as IL-12 plus IL-18. Whereas selection depends on determinants such as CD1d-lipid complexes that bind α β TCR CDRs [48] [49] [50] , the possible contribution(s) of HV4 might merit further study. Indeed, so-called 'super-antigens' , which can profoundly influence development of the α β T cell repertoire, mediate their effects by engaging TCR V β -specific FR3 residues, including HV4, that transduce signals qualitatively distinct from those induced by engagement of CDR1-CDR3 [51] [52] [53] . Similarly, there might be a role (or roles) for HV4 in the antigen receptors of B-1 cells, whose repertoires are seemingly shaped by agonist selection events that also drive the cells' pre-programmed differentiation and association with non-lymphoid tissues 54 . FR3 (HV4) residues of human immunoglobulins seem rarely to be associated with binding of foreign antigen but have been associated with high-affinity binding to autoantigens in patients with central tolerance defects 55 . This might reflect a generalizable ability of HV4 regions to engage endogenous ligands in a growing number of pathophysiologic processes.
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51. Bueno, C. et al. Bacterial superantigens bypass Lck-dependent T cell receptor signaling by activating a Gα 11-dependent, PLC-β -mediated pathway. Isolation of primary IELs. Human colonic lymphocytes were isolated as previously described 22 and used after a 5-to 7-day culture period. Mouse IELs were isolated from small intestine as previously described 22 .
Cell lines. HEK293T cells, HT29 cells, CHO cells (ATCC) and MODE-K cells (a gift from D. Kaiserlian, INSERM U1111, Lyon, France) were maintained in DMEM supplemented with 4.5 g/l d-glucose, l-glutamine, 10% heat-inactivated FCS (FCS) and 1% penicillin-streptomycin. J76 cells, E6.1 cells and PAM2.12 cells were maintained in RPMI 1640 l-glutamine, 10% heat-inactivated FCS and 1% penicillin-streptomycin. All cell culture reagents were from Thermo Fisher. The JRT3 NFAT-Gluc (Gaussia luciferase) reporter cell line 31 was maintained in complete RPMI (above) supplemented with 0.5 mg/ml G418 (Sigma-Aldrich). For transgenic HEK293T cells, MODE-K cells, PAM2.12 cells and CHO cells, medium was supplemented with 1 μ g/ml puromycin (Sigma-Aldrich) and/or 500 μ g/ml hygromycin (Thermo Fisher).
Flow cytometry. Flow cytometry was performed using the following antibodies, coupled to the indicated fluorochromes. These antibodies were purchased from Biolegend unless otherwise stated; viability dies (Blue or Aqua) were from Invitrogen. Antibodies to the following mouse molecules were used: CD3ε -APC/ Cy7 (145-2C11), γ δ TCR-PECy7 (GL3; eBioscience), γ δ TCR-PerCPeFluor710 (GL3), γ δ TCR-PE (GL3), γ δ TCR-BV421 (GL3), V γ 3-BV421 (536; BD Bioscience), V γ 3-APC (536), V δ 4-FITC (GL2), TCRβ -BV421 (H57-597), CD25-PerCP/Cy5.5 (PC61), CD122-PE (TM-β 1), CD71-FITC (RI7217) and Nur77-PerCPeFluor710 (12.14; eBioscience). Antibodies to the following human molecules were used: CD69-AF647 (FN50), CD69-PE (FN50), CD3-FITC (UCHT1), CD3-BV421 (OKT3), CD3-BV786 (OKT3), γ δ TCR-PeCy7 (IMMU510; Beckman Coulter), V δ 1-APC (REA173; Miltenyi), V δ 2-PerCpCy5.5 (B6), CD25-BV421 (BC96) and CD45RA-PE (HI100). The biotin-conjugated antibody to V γ 2 V γ 3 V γ 4 (23D12) 32 was detected by conjugation to PE-streptavidin. Other antibodies were as follows: DYKDDDDK-PE (Flag), DYKDDDDK-APC (Flag), HA-DyLight 650 (2-2.2.14, Invitrogen), HA-BV421 (16B12), HA-AF647 (16B12), EPCR-PE (RCR-16), EPCR-APC (RCR-16). Anti-TCR V γ 7 producing hybridoma (F2.67) was provided by P. Pereira (Institut Pasteur, Paris, France). The antibody was purified from hybridoma supernatant using the mouse TCS purification system (abcam-ab128749) and was conjugated to AF647 (labeling kit, Thermo Fisher Scientific).
Nur77 staining was performed on cells first fixed for 10 min with CellFIX (BD Bioscience), then cells were fixed and permeabilized using the Foxp3/Transcription factor staining buffer set (eBioscience). In one experiment, MODE-K cells were fixed for 10 min with CellFIX and were thoroughly rinsed before co-culture assay.
Flow cytometry data analysis was performed on FlowJo (Version 10).
CD1 protein production and CD1c-PC dextramers. Plasmids encoding the extracellular domains of human CD1c, and human β 2 -microglobulin were separately cloned into the prokaryotic expression vector pET23d (Novagen). CD1c and β 2 -microglobulin were subsequently produced as inclusion bodies in Escherichia coli Rosetta strain (Novagen). Inclusion bodies were thoroughly washed and fully denatured then reduced in 6 M guanidine HCl and 20 mM DTT before in vitro refolding. Refolding of CD1c-β 2 -microglobulin complexes was performed by oxidative in vitro refolding as previously described 56 in the presence of phosphatidylcholine (PC) (Avanti Polar Lipids). Correctly folded proteins were purified by size-exclusion chromatography using preparatory grade SD75 26/60 and analytical grade SD75 GL 10/300 gel filtration columns (GE Healthcare). Refolded CD1c-PC complexes were biotinylated via an engineered BirA motif at the C terminus and were repurified by size-exclusion chromatography before conjugation to dextran-PE (Immudex) to generate labeled CD1c-dextramers 31 .
Co-culture assay. Co-cultures of mouse primary IELs with MODE-K cells and primary human IELs with 293T cells were performed as described previously 22 . 0.5 × 10 5 transduced J76 cells were cultured for 5 h on a confluent monolayer of MODE-K cells, 293T cells, CHO cells and PAM2.12 cells previously seeded in 48-well plates. Alternatively, 0.5 × 10 5 J76 cells, JRT3 NFAT-Gluc cells or transduced E6.1 cells were mixed in 96-well plates with either 2 × 10 5 MODE-K cells or 293T cells, followed by co-culture for 5 h. As control, 0.5 × 10 5 J76 cells were stimulated in 96-well plates with 10 μ g/ml of anti-CD3ε (OKT3; BioLegend) or, for the human TCRs, 'pan' antibody to γ δ TCR (B1; BioLegend), and IgG isotype-matched control antibody (MOPC-21; BioLegend). In EPCR-blocking experiments, 293T cells were pre-incubated for 45 min with 10 μ g/ml antibody to EPCR (AF2245; R&D Systems) or goat IgG (AB-108-C; R&D Systems).
Single-cell PCR and sequencing. A 96-well plate of single-cell-sorted responding cells (CD122   lo   CD25 hi in mouse and TCR lo CD25 hi in human) was thawed on ice, incubated at 65 °C for 5 min and placed back on ice. The reverse transcription and first round of PCR were performed using the qScript XLT One-Step RT-PCR Kit (Quanta Biosciences) following manufacturer's recommendations with slight modifications. External primers sets were used in a 20 µ l reaction (500 nM total concentration for each forward and reverse sets). PCR products were then diluted 1:5 for a second round of PCR using internal sets of primers and Phusion HighFidelity DNA Polymerase (NEB). Second-round PCR products were separated by electrophoresis through a 2% agarose gel, then bands were excised and purified (QIAquick Gel Extraction Kit, Qiagen). Purified amplicons were sent for Sanger sequencing to Eurofins Genomics using custom primers. All primers referred to above are listed in Supplementary Table 2 .
TCR deep sequencing. Human bulk mRNA was extracted from donor biopsies using AllPrep DNA/RNA Mini kit (Qiagen) and was sent for γ δ TCR-chain deep sequencing using the IlluminaMiSeq platform with short-read 100/150 PER primers (iRepertoire). mRNA was extracted from bulk-sorted V γ 7
+ and V γ 7 -IELs using the RNA-Micro-plus kit (QIAGEN). Deep sequencing of mouse Trgv7 and Trdv was performed as described above.
Plasmids and cloning. Full-length γ -and δ -chains were cloned into the selfinactivating lentiviral vector pCSIGPW 22, 23 after removal of the IRES-GFP and CMVp-Puro R cassettes. Overlap-extension PCR (OE-PCR) was used to replace CDR3 regions with AjuI and BaeI restriction sites. Final modified δ -chains were subcloned using XhoI/NotI (for human constructs) or NcoI/XbaI (for mouse constructs); the γ -chain was subcloned using NcoI/XbaI (for human constructs) or PmeI/NotI (for mouse constructs). Human V γ 9 V δ 2 and mouse V γ 5 V δ 1 pCSIW constructs were made with no restriction-site modifications. Paired CDR3γ and CDR3δ sequences were cloned using short annealed oligonucleotides. Plasmids encoding Btnl or BTNL protein tagged at the amino terminus were described 23 . EPCR was cloned from HT29 cDNA into pCSIGPW using XhoI/NotI restriction sites. T22 was cloned from small intestine cDNA of a C57BL/6 mouse into pCSIGPW using PmeI/NotI restriction sites. Mutations to swap CDR HV4 regions or amino acids (TCRs), solvent-exposed IgV-amino acids (BTNL3 and BTNL8) or to remove endogenous restriction sites by introduction of silent mutations were all performed by OE-PCR. Lentiviral production and transduction. All plasmids used for lentiviral transduction were purified using a NucleoBond Xtra Midi EF kit (MachereyNagel). Lentiviral particles were produced in HEK293T cells by co-transfection of pCSIW encoding different TCRs, HIV-1 gag-pol pCR/V1 57 and VSV-G env pHIT/ G 58 . Medium was replaced 16 h after transfection and was collected at 48 h, filtered through 0.45-μ m nylon mesh and used to transduce 1 × 10 5 to 2.5 × 10 5 J76 cells, E6.1 cells or JRT3 NFAT-Gluc cells by spinoculation at 1,000 g for 30 min. Cells were assessed for TCR expression after 2-5 d. Adherent cell lines were transduced with the indicated combinations of FLAG-BTNL3, HA-BTNL8, HA-Btnl6, His-T22 and EPCR cloned into pCSIGPW, and FLAG-Btnl1 cloned into pCSIYHW. Viral supernatant supplemented with polybrene (1 μ g/ml) was added to 50% confluent cells plated 24 h before transduction. 48 h after transduction, medium was supplemented with the appropriate concentration of antibiotics (hygromycin and/ or puromycin) and, where necessary, cells were sorted on the basis of expression of green fluorescent protein (GFP) and/or the tag.
Co-immunoprecipitation and mass spectrometry. Lysates of MODE-K cells transduced with an empty vector (EV) or with FLAG-Btnl1 and HA-Btnl6 were incubated with anti-DYKDDDDK magnetic agarose beads, followed by protein elution and SDS/PAGE. Anti-FLAG immunoprecipitation and mass-spectrometry analysis were performed as previously described 23 .
Immunoblot analysis. Cell lines were kept overnight in 'starving medium' (RPMI and 0.5% FBS), then were harvested, washed with 'starving medium' and allowed to 'rest' in suspension for 1 h at 37 °C and 5% CO 2 . 2.5 × 10 5 JRT3-LES cells were mixed with 6.25 × 10 5 stimulatory cells or with 10 μ g/ml anti-CD3ε (UCHT1; BioLegend) and 10 μ g/ml pan-γ δ TCR (B1; BioLegend) crosslinked with antibody to mouse IgG (Poly4053; Biolegend). Cells were spun down at 600 g for 1 min and were incubated at 37 °C. 1 ml ice-cold PBS was then added at 5, 10 and 20 min, and samples were spun down at 600 g for 2 min at 4 °C. 2.5 × 10 5 J76-mo8 cells were mixed with 5 × 10 5 MODE-K cells expressing empty vector, l1l6 and/or T22 or with 10 μ g/ml anti-CD3ε (OKT3; BioLegend), anti-CD3ε (UCHT1; BioLegend) and 'pan' antibody to γ δ TCR (GL3; BioLegend) crosslinked with antibody to mouse IgG (Poly4053; BioLegend) or to hamster IgG (BA-9100; Vector Laboratories). Cells were spun down at 600 g for 1 min and were incubated for 10 min at 37 °C. Pellets were then re-suspended in 100 μ l ice-cold lysis buffer (50 mM Tris, pH 8, 150 mM NaCl, 0.5% NP-40, and Protease and Phosphatase Inhibitor Cocktail
